Skip to main content
Top
Published in: Heart and Vessels 8/2019

01-08-2019 | Arterial Occlusive Disease | Original Article

Linc00299/miR-490-3p/AURKA axis regulates cell growth and migration in atherosclerosis

Authors: Yong Liu, Yaqing Chen, Lili Tan, Hongmei Zhao, Nuan Xiao

Published in: Heart and Vessels | Issue 8/2019

Login to get access

Abstract

Long non-coding RNA (lncRNA) plays a crucial role in regulating various cellular processes in atherosclerosis. The present study identified the regulation of Linc00299, via miR-490-3p targeting Aurora kinase A (AURKA), on migration and proliferation of endothelial cells and vascular smooth muscle cells (VSMCs) during atherosclerosis. The expression of RNAs was assessed by real-time PCR. The proliferation, apoptosis and migration were detected using MTT assay, Annexin V/PI staining and Transwell system, respectively. Bindings of Linc00299/miR-490-3p and subsequent miR-490-3p/AURKA were verified by luciferase and biotin pull-down assays. The protein expression of AURKA was detected by Western blotting. Expressions of Linc00299 and miR-490-3p were upregulated and downregulated in atherosclerosis patients, respectively. Both Linc00299 knockdown and miR-490-3p overexpression suppressed cell proliferation, increased apoptosis and inhibited migration of VSMCs and HUVECs. Linc00299 directly bound to miR-490-3p which targeted AURKA. The regulation of Linc00299 on expression of AURKA and proliferation and migration of VSMCs were dependent on miR-490-3p. Atherosclerosis-increased Linc00299 acts as a sponge of miR-490-3p to upregulate AURKA, and as a result increases proliferation and migration in VSMCs and HUVECs. Our study reveals an important effect of Linc00299/miR-490-3p/AURKA axis on regulating cell proliferation and migration in atherosclerosis.
Literature
1.
go back to reference Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O'Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Council on E, Prevention Statistics C, Stroke Statistics S (2018) Heart disease and stroke statistics-2018 update: a report from the American heart association. Circulation 137:e67–e492 Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O'Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Council on E, Prevention Statistics C, Stroke Statistics S (2018) Heart disease and stroke statistics-2018 update: a report from the American heart association. Circulation 137:e67–e492
2.
go back to reference Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695CrossRefPubMed Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695CrossRefPubMed
4.
go back to reference Pober JS, Min W, Bradley JR (2009) Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 4:71–95CrossRefPubMed Pober JS, Min W, Bradley JR (2009) Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 4:71–95CrossRefPubMed
6.
go back to reference Wang D, Uhrin P, Mocan A, Waltenberger B, Breuss JM, Tewari D, Mihaly-Bison J, Huminiecki L, Starzynski RR, Tzvetkov NT, Horbanczuk J, Atanasov AG (2018) Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways. Biotechnol Adv 36(6):1586–1607CrossRefPubMed Wang D, Uhrin P, Mocan A, Waltenberger B, Breuss JM, Tewari D, Mihaly-Bison J, Huminiecki L, Starzynski RR, Tzvetkov NT, Horbanczuk J, Atanasov AG (2018) Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways. Biotechnol Adv 36(6):1586–1607CrossRefPubMed
7.
go back to reference Jansen F, Li Q, Pfeifer A, Werner N (2017) Endothelial- and immune cell-derived extracellular vesicles in the regulation of cardiovascular health and disease. JACC Basic Transl Sci 2:790–807CrossRefPubMedPubMedCentral Jansen F, Li Q, Pfeifer A, Werner N (2017) Endothelial- and immune cell-derived extracellular vesicles in the regulation of cardiovascular health and disease. JACC Basic Transl Sci 2:790–807CrossRefPubMedPubMedCentral
8.
go back to reference Quinn JJ, Chang HY (2016) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17:47–62CrossRefPubMed Quinn JJ, Chang HY (2016) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17:47–62CrossRefPubMed
9.
10.
go back to reference Wang K, Liu F, Zhou LY, Long B, Yuan SM, Wang Y, Liu CY, Sun T, Zhang XJ, Li PF (2014) The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res 114:1377–1388CrossRefPubMed Wang K, Liu F, Zhou LY, Long B, Yuan SM, Wang Y, Liu CY, Sun T, Zhang XJ, Li PF (2014) The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res 114:1377–1388CrossRefPubMed
12.
go back to reference Jian L, Jian D, Chen Q, Zhang L (2016) Long noncoding RNAs in atherosclerosis. J Atheroscler Thromb 23:376–384CrossRefPubMed Jian L, Jian D, Chen Q, Zhang L (2016) Long noncoding RNAs in atherosclerosis. J Atheroscler Thromb 23:376–384CrossRefPubMed
13.
go back to reference Talkowski ME, Maussion G, Crapper L, Rosenfeld JA, Blumenthal I, Hanscom C, Chiang C, Lindgren A, Pereira S, Ruderfer D, Diallo AB, Lopez JP, Turecki G, Chen ES, Gigek C, Harris DJ, Lip V, An Y, Biagioli M, Macdonald ME, Lin M, Haggarty SJ, Sklar P, Purcell S, Kellis M, Schwartz S, Shaffer LG, Natowicz MR, Shen Y, Morton CC, Gusella JF, Ernst C (2012) Disruption of a large intergenic noncoding RNA in subjects with neurodevelopmental disabilities. Am J Hum Genet 91:1128–1134CrossRefPubMedPubMedCentral Talkowski ME, Maussion G, Crapper L, Rosenfeld JA, Blumenthal I, Hanscom C, Chiang C, Lindgren A, Pereira S, Ruderfer D, Diallo AB, Lopez JP, Turecki G, Chen ES, Gigek C, Harris DJ, Lip V, An Y, Biagioli M, Macdonald ME, Lin M, Haggarty SJ, Sklar P, Purcell S, Kellis M, Schwartz S, Shaffer LG, Natowicz MR, Shen Y, Morton CC, Gusella JF, Ernst C (2012) Disruption of a large intergenic noncoding RNA in subjects with neurodevelopmental disabilities. Am J Hum Genet 91:1128–1134CrossRefPubMedPubMedCentral
14.
go back to reference Yang J, Chen L, Yang J, Ding J, Rong H, Dong W, Li X (2012) High mobility group box-1 induces migration of vascular smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation. Mol Biol Rep 39:3361–3367CrossRefPubMed Yang J, Chen L, Yang J, Ding J, Rong H, Dong W, Li X (2012) High mobility group box-1 induces migration of vascular smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation. Mol Biol Rep 39:3361–3367CrossRefPubMed
15.
go back to reference Li J, Zhang Z, Xiong L, Guo C, Jiang T, Zeng L, Li G, Wang J (2017) SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer. Biochem Biophys Res Commun 487:146–152CrossRefPubMed Li J, Zhang Z, Xiong L, Guo C, Jiang T, Zeng L, Li G, Wang J (2017) SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer. Biochem Biophys Res Commun 487:146–152CrossRefPubMed
16.
go back to reference Zhang P, Cao L, Fan P, Mei Y, Wu M (2016) LncRNA-MIF, a c-Myc-activated long non-coding RNA, suppresses glycolysis by promoting Fbxw7-mediated c-Myc degradation. EMBO Rep 17:1204–1220CrossRefPubMedPubMedCentral Zhang P, Cao L, Fan P, Mei Y, Wu M (2016) LncRNA-MIF, a c-Myc-activated long non-coding RNA, suppresses glycolysis by promoting Fbxw7-mediated c-Myc degradation. EMBO Rep 17:1204–1220CrossRefPubMedPubMedCentral
17.
go back to reference Li P, Yang X, Yuan W, Yang C, Zhang X, Han J, Wang J, Deng X, Yang H, Li P, Tao J, Lu Q, Gu M (2018) CircRNA-Cdr1as exerts anti-oncogenic functions in bladder cancer by sponging microRNA-135a. Cell Physiol Biochem 46:1606–1616CrossRefPubMed Li P, Yang X, Yuan W, Yang C, Zhang X, Han J, Wang J, Deng X, Yang H, Li P, Tao J, Lu Q, Gu M (2018) CircRNA-Cdr1as exerts anti-oncogenic functions in bladder cancer by sponging microRNA-135a. Cell Physiol Biochem 46:1606–1616CrossRefPubMed
18.
go back to reference Boon RA, Jae N, Holdt L, Dimmeler S (2016) Long noncoding RNAs: from clinical genetics to therapeutic targets? J Am Coll Cardiol 67:1214–1226CrossRefPubMed Boon RA, Jae N, Holdt L, Dimmeler S (2016) Long noncoding RNAs: from clinical genetics to therapeutic targets? J Am Coll Cardiol 67:1214–1226CrossRefPubMed
19.
go back to reference Blake J, Riddell A, Theiss S, Gonzalez AP, Haase B, Jauch A, Janssen JW, Ibberson D, Pavlinic D, Moog U, Benes V, Runz H (2014) Sequencing of a patient with balanced chromosome abnormalities and neurodevelopmental disease identifies disruption of multiple high risk loci by structural variation. PLoS ONE 9:e90894CrossRefPubMedPubMedCentral Blake J, Riddell A, Theiss S, Gonzalez AP, Haase B, Jauch A, Janssen JW, Ibberson D, Pavlinic D, Moog U, Benes V, Runz H (2014) Sequencing of a patient with balanced chromosome abnormalities and neurodevelopmental disease identifies disruption of multiple high risk loci by structural variation. PLoS ONE 9:e90894CrossRefPubMedPubMedCentral
20.
go back to reference Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I (2011) A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147:358–369CrossRefPubMedPubMedCentral Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I (2011) A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147:358–369CrossRefPubMedPubMedCentral
22.
go back to reference Damodaran AP, Vaufrey L, Gavard O, Prigent C (2017) Aurora A kinase is a priority pharmaceutical target for the treatment of cancers. Trends Pharmacol Sci 38:687–700CrossRefPubMed Damodaran AP, Vaufrey L, Gavard O, Prigent C (2017) Aurora A kinase is a priority pharmaceutical target for the treatment of cancers. Trends Pharmacol Sci 38:687–700CrossRefPubMed
24.
go back to reference Vo TTL, Park JH, Seo JH, Lee EJ, Choi H, Bae SJ, Le H, An S, Lee HS, Wee HJ, Kim KW (2017) ARD1-mediated aurora kinase A acetylation promotes cell proliferation and migration. Oncotarget 8:57216–57230PubMedPubMedCentral Vo TTL, Park JH, Seo JH, Lee EJ, Choi H, Bae SJ, Le H, An S, Lee HS, Wee HJ, Kim KW (2017) ARD1-mediated aurora kinase A acetylation promotes cell proliferation and migration. Oncotarget 8:57216–57230PubMedPubMedCentral
25.
go back to reference Yuan Q, Sun T, Ye F, Kong W, Jin H (2017) MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA. Cancer Biomark 19:93–101CrossRefPubMed Yuan Q, Sun T, Ye F, Kong W, Jin H (2017) MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA. Cancer Biomark 19:93–101CrossRefPubMed
Metadata
Title
Linc00299/miR-490-3p/AURKA axis regulates cell growth and migration in atherosclerosis
Authors
Yong Liu
Yaqing Chen
Lili Tan
Hongmei Zhao
Nuan Xiao
Publication date
01-08-2019
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 8/2019
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-019-01356-7

Other articles of this Issue 8/2019

Heart and Vessels 8/2019 Go to the issue